Tag: drug
RSV Prophylactic Beyfortus: Potential Competitors and Market Trends
Alnylam Pharmaceuticals, led by CEO Yvonne Greenstreet, is making strides in expanding the use of its RNA-based gene-silencing heart drug, vutrisiran. The drug has shown promising results in reducing the risk of death and...
The Risks of the Latest Schizophrenia Miracle Drug: What You Need to Know
The recent FDA approval of Cobenfy, a new antipsychotic drug, has sparked both hope and skepticism within the mental health community, particularly among those with schizophrenia and bipolar disorder. While this development represents progress...
Expanding Access to HIV Prevention Drug: ViiV Faces Criticism
ViiV Healthcare recently announced plans to increase access to its HIV prevention medication in low- and middle-income countries. This marks the second time in two years that the company has taken such steps. Despite...
Scholar Rock’s Drug Shows Success in Late-Stage Study for Spinal Muscular Atrophy
Scholar Rock, a biotech company, announced on Monday that their new drug has shown promising results in a late-stage study for spinal muscular atrophy. The drug, called apitegromab, was tested in a year-long Phase...